secwatch.observer — SEC 8-K summary
======================================

Issuer:     MAXCYTE, INC. (MXCT)
CIK:        0001287098
Form:       8-K
Filed at:   2021-11-10T23:59:59+00:00
Accession:  0001104659-21-136950
Event type: earnings
Sentiment:  positive
Materiality: 0.65
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

MaxCyte Q3 revenue up 50% to $10.1M; raises FY2021 guidance to at least $33M
----------------------------------------------------------------------------

- Total revenue $10.1M (+50% YoY); net loss ($2.7M) improved from ($3.1M) prior year.
- SPL Program-related revenue $2.0M (record quarter) vs $0.3M YoY; 15 SPL agreements now.
- FY2021 revenue guidance raised to at least $33M from prior outlook of >$30M.
- Gross margin 91% (up from 89%); cash and equivalents $255.9M as of Sept 30.
- James Lovgren appointed SVP Global Marketing; previously VP at Berkeley Lights.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1287098/000110465921136950/0001104659-21-136950-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1287098/000110465921136950/tm2132517d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-21-136950

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer